Pathogenesis and medical management of cystinuria

Research output: Contribution to journalArticle

37 Citations (Scopus)

Abstract

Cystinuria is an inheritable disorder of amino acid transport, transmitted as an autosomal recessive trait. Cystinuria is caused by defective transport of cystine and dibasic amino acids through the epithelial cells of the renal tubule and intestinal tract. Cystine stones are caused by the excessive renal excretion of cystine as a result of its low solubility in urine. Recently, a human kidney cDNA, named rBAT (also D2: the gene now designated SLC3A1), which elicits the transport for cystine and dibasic amino acids, has been reported. The 90-kd Type II glycoprotein stimulated cystine and dibasic and neutral amino acid uptake into oocytes with kinetics similar to the renal brush border transporter. The human gene for this protein resides on chromosome 2. The most frequent mutations found involved substitution of the threonine for methionine 467. Eight additional mutations in SLC3A1 have been found. Cystine stones frequently occur in the second or third decade of life, with an occasional occurrence in infancy and in old age. Urinary cystine excretion exceeding 250 mg/g creatinine is usually diagnostic of homozygous cystinuria. The goal of treatment is to reduce the urinary cystine concentration below its solubility limit (250 mg/L).

Original languageEnglish (US)
Pages (from-to)435-447
Number of pages13
JournalSeminars in Nephrology
Volume16
Issue number5
StatePublished - 1996

Fingerprint

Cystinuria
Cystine
Diamino Amino Acids
Kidney
Solubility
Neutral Amino Acids
Mutation
Chromosomes, Human, Pair 2
Threonine
Microvilli
Methionine
Oocytes
Creatinine
Glycoproteins
Complementary DNA
Epithelial Cells
Urine
Amino Acids

ASJC Scopus subject areas

  • Nephrology

Cite this

Pathogenesis and medical management of cystinuria. / Sakhaee, Khashayar.

In: Seminars in Nephrology, Vol. 16, No. 5, 1996, p. 435-447.

Research output: Contribution to journalArticle

@article{736e1efa6b5644a8afeaffa0019d0eb0,
title = "Pathogenesis and medical management of cystinuria",
abstract = "Cystinuria is an inheritable disorder of amino acid transport, transmitted as an autosomal recessive trait. Cystinuria is caused by defective transport of cystine and dibasic amino acids through the epithelial cells of the renal tubule and intestinal tract. Cystine stones are caused by the excessive renal excretion of cystine as a result of its low solubility in urine. Recently, a human kidney cDNA, named rBAT (also D2: the gene now designated SLC3A1), which elicits the transport for cystine and dibasic amino acids, has been reported. The 90-kd Type II glycoprotein stimulated cystine and dibasic and neutral amino acid uptake into oocytes with kinetics similar to the renal brush border transporter. The human gene for this protein resides on chromosome 2. The most frequent mutations found involved substitution of the threonine for methionine 467. Eight additional mutations in SLC3A1 have been found. Cystine stones frequently occur in the second or third decade of life, with an occasional occurrence in infancy and in old age. Urinary cystine excretion exceeding 250 mg/g creatinine is usually diagnostic of homozygous cystinuria. The goal of treatment is to reduce the urinary cystine concentration below its solubility limit (250 mg/L).",
author = "Khashayar Sakhaee",
year = "1996",
language = "English (US)",
volume = "16",
pages = "435--447",
journal = "Seminars in Nephrology",
issn = "0270-9295",
publisher = "W.B. Saunders Ltd",
number = "5",

}

TY - JOUR

T1 - Pathogenesis and medical management of cystinuria

AU - Sakhaee, Khashayar

PY - 1996

Y1 - 1996

N2 - Cystinuria is an inheritable disorder of amino acid transport, transmitted as an autosomal recessive trait. Cystinuria is caused by defective transport of cystine and dibasic amino acids through the epithelial cells of the renal tubule and intestinal tract. Cystine stones are caused by the excessive renal excretion of cystine as a result of its low solubility in urine. Recently, a human kidney cDNA, named rBAT (also D2: the gene now designated SLC3A1), which elicits the transport for cystine and dibasic amino acids, has been reported. The 90-kd Type II glycoprotein stimulated cystine and dibasic and neutral amino acid uptake into oocytes with kinetics similar to the renal brush border transporter. The human gene for this protein resides on chromosome 2. The most frequent mutations found involved substitution of the threonine for methionine 467. Eight additional mutations in SLC3A1 have been found. Cystine stones frequently occur in the second or third decade of life, with an occasional occurrence in infancy and in old age. Urinary cystine excretion exceeding 250 mg/g creatinine is usually diagnostic of homozygous cystinuria. The goal of treatment is to reduce the urinary cystine concentration below its solubility limit (250 mg/L).

AB - Cystinuria is an inheritable disorder of amino acid transport, transmitted as an autosomal recessive trait. Cystinuria is caused by defective transport of cystine and dibasic amino acids through the epithelial cells of the renal tubule and intestinal tract. Cystine stones are caused by the excessive renal excretion of cystine as a result of its low solubility in urine. Recently, a human kidney cDNA, named rBAT (also D2: the gene now designated SLC3A1), which elicits the transport for cystine and dibasic amino acids, has been reported. The 90-kd Type II glycoprotein stimulated cystine and dibasic and neutral amino acid uptake into oocytes with kinetics similar to the renal brush border transporter. The human gene for this protein resides on chromosome 2. The most frequent mutations found involved substitution of the threonine for methionine 467. Eight additional mutations in SLC3A1 have been found. Cystine stones frequently occur in the second or third decade of life, with an occasional occurrence in infancy and in old age. Urinary cystine excretion exceeding 250 mg/g creatinine is usually diagnostic of homozygous cystinuria. The goal of treatment is to reduce the urinary cystine concentration below its solubility limit (250 mg/L).

UR - http://www.scopus.com/inward/record.url?scp=0029770703&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029770703&partnerID=8YFLogxK

M3 - Article

C2 - 8890399

AN - SCOPUS:0029770703

VL - 16

SP - 435

EP - 447

JO - Seminars in Nephrology

JF - Seminars in Nephrology

SN - 0270-9295

IS - 5

ER -